Placebo News and Research

RSS

Specific diets have less effect on IBS symptoms than expected

Many IBS sufferers avoid certain types of food and often exclude gluten. However, a large new study from Chalmers University of Technology and Uppsala University, Sweden, does not show a relationship between high intake of gluten and increased IBS symptoms.

16 Dec 2021

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.

16 Dec 2021

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

A new study assesses the safety and efficacy of SARS-CoV-2 convalescent plasma containing high titers of anti-SARS-CoV-2 antibodies as PEP.

16 Dec 2021

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Scientists have recently reported the efficacy of carrageenan against both the SARS-CoV-2 original strain as well as the Alpha, Beta, Gamma, and Delta VOCs.

13 Dec 2021

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care investigated whether nivolumab has an added benefit over watchful waiting in the adjuvant treatment of adults with carcinoma of the esophagus or the gastroesophageal junction and pathological residual disease after prior neoadjuvant chemoradiotherapy (CRT).

10 Dec 2021

NRG Oncology CC004 trial: Bupropion does not improve sexual desire for female cancer survivors

Despite preliminary supporting evidence that the dopaminergic agent bupropion might improve sexual desire for female cancer survivors, the NRG Oncology CC004 clinical trial determined that bupropion did not improve outcomes when compared to a placebo.

10 Dec 2021

Online single-session interventions help curb teen depression, study shows

A study of more than 2,400 adolescents ages 13 to 16 shows two online, single-session interventions designed to help curb teen depression works, a tool very much needed given a rise in teen depression and loss of some in-person mental health services during the Covid-19 pandemic.

9 Dec 2021

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11.

9 Dec 2021

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline today announce positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, conducted in over 24,000 subjects, adults 18 years and above, across six countries.

9 Dec 2021

Electronic nicotine delivery systems may help some people stop smoking cigarettes

Electronic cigarettes with cigarette-like nicotine delivery may help some people stop smoking cigarettes, according to a new study by Penn State College of Medicine and Virginia Commonwealth University researchers.

8 Dec 2021

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination.

7 Dec 2021

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Researchers have presented the results of phase 1 and phase 2 clinical trials of a SARS-CoV-2 recombinant spike protein vaccine (Abdala).

6 Dec 2021

Diabetes medication could revolutionize treatment for heart failure

A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionize treatment, according to new research from the University of East Anglia.

1 Dec 2021

Caffeine increases alertness and detection accuracy for moving targets

In the first study of its kind to explore caffeine's effects on dynamic visual skills, researchers concluded that caffeine increases alertness and detection accuracy for moving targets. Caffeine also improved participants' reaction times.

1 Dec 2021

Unvaccinated white evangelicals seem to be resistant to persuasive pro-vaccine messages

White evangelical Christians have resisted getting vaccinated against COVID-19 at higher rates than other religious groups in the United States. A new study by Yale researchers provides evidence that persuading these vaccine holdouts to get their shots has only gotten more difficult.

30 Nov 2021

Study compares NAbs from natural SARS-CoV-2 infection vs. vaccine induced against symptomatic infection

Scientists have recently compared the levels of antibody concentrations in unvaccinated, SARS-CoV-2 convalescent individuals and COVID-19 specific antibodies in vaccinated individuals.

30 Nov 2021

Teriflunomide tempers lesion growth in pediatric patients with multiple sclerosis

There are few treatment options for children with multiple sclerosis - a condition in which the immune system attacks the protective covering of nerves in the brain and spinal cord - and most therapies for the disease have not been tested in children.

30 Nov 2021

Placebo News and Research

Specific diets have less effect on IBS symptoms than expected

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

NRG Oncology CC004 trial: Bupropion does not improve sexual desire for female cancer survivors

Online single-session interventions help curb teen depression, study shows

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Electronic nicotine delivery systems may help some people stop smoking cigarettes

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine

Diabetes medication could revolutionize treatment for heart failure

Caffeine increases alertness and detection accuracy for moving targets

Unvaccinated white evangelicals seem to be resistant to persuasive pro-vaccine messages

Study compares NAbs from natural SARS-CoV-2 infection vs. vaccine induced against symptomatic infection

Teriflunomide tempers lesion growth in pediatric patients with multiple sclerosis

Heart failure patients may benefit from common type 2 diabetes drug

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News